Disease Info Card

Neurofibromatosis 2

Information about Neurofibromatosis 2: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Neurofibromatosis 2

Most recent studies have shown that Neurofibromatosis 2 shares some biological mechanisms with acoustic-neuroma, acoustic-neuroma, brain-neoplasms, brain-neoplasms, cell-transformation-neoplastic, cell-transformation-neoplastic, complete-hearing-loss, cranial-nerve-neoplasms, ependymoma, ependymoma, glioma, glioma, hamartoma, hereditary-diseases, malignant-neoplasms, malignant-neoplasms, malignant-paraganglionic-neoplasm, malignant-paraganglionic-neoplasm, meningeal-neoplasms, meningeal-neoplasms, meningioma, meningioma, neoplasms, neoplasms, nervous-system-neoplasms, nervous-system-neoplasms, nervousness, nervousness, neurilemmoma, neurilemmoma, neurofibroma, neurofibroma, neurofibromatoses, neurofibromatoses, neurofibromatosis-1, neurofibromatosis-1, neurofibromatosis-2, neuroma, neuroma, schwannomatosis.

Among the many pathways, these few ones have gauged particular interests from scientists studying Neurofibromatosis 2, and have been seen in publications frequently: Angiogenesis, Cell Adhesion, Cell Adhesion, Cell Cycle, Cell Cycle, Cell Differentiation, Cell Differentiation, Cell Growth, Cell Growth, Cell Migration, Cell Migration, Cell Motility, Cell Motility, Cell Proliferation, Cell Proliferation, Contact Inhibition, Contact Inhibition, Cytokinesis, Endocytosis, Endocytosis, Localization, Localization, Methylation, Nuclear Export, Oncogenesis, Oncogenesis, Ossification, Pathogenesis, Pathogenesis, Reflex, Regulation Of Cell Growth, Regulation Of Cell Proliferation, Reverse Transcription, Schwann Cell Proliferation, Spermatogenesis, Translation, Translation, Transport

Quite a number of genes have been found to play important roles in Neurofibromatosis 2, such as AKT1, AKT1, ATN1, CD44, CDKN2A, CDKN2A, EGFR, EGFR, EPB41, EPB41L3, EPB41L3, EZR, EZR, HGS, KIT, MAPK1, MAPK1, MED28, MSN, MSN, NF1, NF1, NF2, NF2, NFASC, PTEN, RB1, RDX, RDX, SMARCB1, SRSF5, TP53, TP53, YAP1. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.